Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling (Q38993553)

8 September 2017

title

Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling (English)

1 reference

8 September 2017

1 reference

Ke Huang

1

1 reference

8 September 2017

Li-an Li

2

1 reference

8 September 2017

Yuan-guang Meng

3

1 reference

8 September 2017

Yan-qin You

4

1 reference

8 September 2017

Xiao-yu Fu

5

1 reference

8 September 2017

Lei Song

6

1 reference

8 September 2017

publication date

17 June 2014

1 reference

Basic and Clinical Pharmacology and Toxicology

8 September 2017

published in

1 reference

8 September 2017

volume

115

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

507-511

1 reference

8 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Therapeutic targeting of the Jak/STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

STAT3 regulation by S-nitrosylation: implication for inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12270

21 January 2018

Identifiers

DOI

10.1111/BCPT.12270

1 reference

8 September 2017

1 reference